MEXITIL Drug Patent Profile
✉ Email this page to a colleague
When do Mexitil patents expire, and what generic alternatives are available?
Mexitil is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in MEXITIL is mexiletine hydrochloride. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mexitil
A generic version of MEXITIL was approved as mexiletine hydrochloride by TEVA on May 16th, 1995.
Summary for MEXITIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 214 |
Clinical Trials: | 4 |
Patent Applications: | 4,196 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEXITIL at DailyMed |
Recent Clinical Trials for MEXITIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Massachusetts General Hospital | Phase 2 |
Food and Drug Administration (FDA) | Phase 1 |
Spaulding Clinical Research LLC | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for MEXITIL
US Patents and Regulatory Information for MEXITIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | MEXITIL | mexiletine hydrochloride | CAPSULE;ORAL | 018873-002 | Dec 30, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | MEXITIL | mexiletine hydrochloride | CAPSULE;ORAL | 018873-003 | Dec 30, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | MEXITIL | mexiletine hydrochloride | CAPSULE;ORAL | 018873-004 | Dec 30, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MEXITIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | MEXITIL | mexiletine hydrochloride | CAPSULE;ORAL | 018873-003 | Dec 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | MEXITIL | mexiletine hydrochloride | CAPSULE;ORAL | 018873-003 | Dec 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | MEXITIL | mexiletine hydrochloride | CAPSULE;ORAL | 018873-002 | Dec 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MEXITIL
See the table below for patents covering MEXITIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 7521 | ⤷ Try a Trial | |
Switzerland | 516512 | Verfahren zur Herstellung neuer substituierter 1-Phenoxy-2-aminopropane | ⤷ Try a Trial |
United Kingdom | 1205956 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |